New York Senate Bill S02383

New York 2025-2026 Regular Session

• Introduced: 1/16/25
• Refer: 1/16/25

Caption

Relates to the classification of the drug xylazine as a schedule I controlled substance, and to the criminal sale and possession of xylazine or preparations, compounds, mixtures or substances containing xylazine.